<i>Epimedium brevicornu</i> Maxim. extract activates natural killer cells against hepatocellular carcinoma via the cGAS-STING pathway. [PDF]
Liu L +11 more
europepmc +1 more source
This study integrated early‐stage patient specimens with publicly available datasets encompassing non‐malignant lung tissues and advanced‐stage LUAD through single‐cell sequencing, revealing a dynamically remodeled tumor microenvironment characterized by a hypoxia‐adapted malignant subset (C5), immunosuppressive LGMN+ macrophages, STAT1‐driven ...
Bomiao Qing +10 more
wiley +1 more source
Natural killer cells and IFN-γ protect against liver injury during HAV infection in mice. [PDF]
Misumi I +6 more
europepmc +1 more source
This study designs a novel mRNA‐LNP vaccine targeting VZV glycoprotein E (gE) for herpes zoster via an AI‐assisted pipeline. Validated in mice and rhesus macaques, the mRNA‐LNP vaccine shows strong humoral and cellular immune responses, with CD4+ T‐cell responses more effective and durable than Shingrix, offering a promising prophylactic option ...
Kai Dong +6 more
wiley +1 more source
Non-canonical inflammasome drives intrinsic anti-microbial responses in human Natural Killer cells
Leborgne NG +21 more
europepmc +1 more source
Natural Killer Cells Are Dispensable for Virus Control in Rag2<sup>-/-</sup> Mice During Primary RSV Infection. [PDF]
Nakawesi J, Sow Tao Min T, Johansson C.
europepmc +1 more source
Rapid Microfluidic Drug Sensitivity Testing Within 5 Days Using Minimal Clinical Tumor Samples
This study develops the air‐punched fabrication approach for nanoliter‐scale microcavity arrays with ultra‐smooth microcavity surfaces, with which rapid formation and 3D culture of tumor cell spheroids from small numbers of cell samples, as well as high‐throughput drug sensitivity testing can be achieved within 5 days.
Yi‐Xue Chen +11 more
wiley +1 more source
Modular Droplet-Based Microfluidic Platform for Functional Phenotypic Screening of Natural Killer Cells. [PDF]
Aubermann F +8 more
europepmc +1 more source
LMO7 Suppresses Tumor‐Associated Macrophage Phagocytosis of Tumor Cells Through Degradation of LRP1
LMO7 in tumor‐associated macrophages suppresses phagocytosis of tumor cells and limits cytotoxic T lymphocytes infiltration, fostering tumor progression. Mechanistically, LMO7 mediates the ubiquitination and degradation of the phagocytic receptor LRP1, impairing its ability to engulf tumor cells and driving macrophages toward an antitumor phenotype ...
Mengkai Li +12 more
wiley +1 more source

